Overview
This is an individually randomized cross-over trial to assess acceptability, preference, and perceived side effects of MMS formulations with 30 mg, 45 mg and 60 mg of iron.
Eligibility
Inclusion Criteria:
- Attending first ANC visit at the study clinic
- Pregnant women ≤ 15 weeks of gestation
- Aged ≥ 18 years
- Intending to stay in Dar es Salaam for the duration of study
- Provides informed consent
Exclusion Criteria:
- Severe anemia (defined as Hb <8.5 g/dL per Tanzania standard of care)
- Sickle cell disease (SS,SC, CC genotype) as tested by HemoTypeSC
- Concurrent participation in other nutritional supplementation trial
- Pregnant women with disability or condition which would impair their ability to provide informed consent and complete study procedures.